Nutritional Composition Synergy MFGM HMOs Bioavailability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nutritional compositions often rely on expensive exotic ingredients for marginal improvements in bioavailability, lacking synergistic combinations that could enhance the development and health of humans across all ages while minimizing health risks.
Innovation Solution
A nutritional composition comprising a milk fat globule membrane component, at least one human milk oligosaccharide, and additional components like DHA, ARA, Vitamin E, Vitamin C, and sphingomyelin, which work synergistically to increase the bioavailability of key nutrients such as DHA and alpha-tocopherol, enhancing cognitive, visual, and mental health.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If expensive exotic ingredients are used in nutritional compositions, then bioavailability improvement is achieved, but cost increases significantly
Solution Approach 1:
The patent combines multiple ingredients (MFGM, HMOs, DHA, ARA, Vitamin E, Vitamin C, and sphingomyelin) into a composite nutritional formulation. This composite approach creates synergistic effects where the combination of components enhances bioavailability more effectively than individual exotic ingredients alone, while distributing cost across multiple more affordable components rather than relying on single expensive additives.
Solution Approach 2:
The patent merges traditionally separate nutritional components into a unified formulation. By combining MFGM with HMOs and fat supplements in specific ratios, the invention creates a integrated system where components work together to enhance absorption and utilization of nutrients, achieving reliable bioavailability improvement through collaboration of multiple ingredients rather than dependence on single expensive additives.
2Quantity of substance
If standard ingredients are used in nutritional compositions, then cost is reduced, but bioavailability improvement is marginal
Solution Approach 1:
The patent optimizes the parameters of the formulation by specifying precise ratios and concentrations of each component. The MFGM is provided at 0.1-10% w/w, HMOs at 0.1-10% w/w, and fat supplements at 0.1-20% w/w, with DHA specifically at 0.01-2% w/w. These parameter optimizations ensure that each ingredient contributes maximally to bioavailability within cost-effective ranges, avoiding both under-dosing (marginal effect) and over-dosing (excessive cost).
Solution Approach 2:
The patent creates a composite formulation where standard ingredients are combined in specific proportions to achieve synergistic bioavailability enhancement. The combination of MFGM, HMOs, and fat supplements with defined ratios transforms individually modest ingredients into a collectively potent formulation that delivers significant bioavailability improvement without requiring expensive exotic additives in high concentrations.
3Reliability
If synergistic ingredient combinations are developed, then health benefits are enhanced, but formulation complexity increases
Solution Approach 1:
The patent segments the nutritional formulation into distinct functional modules: MFGM (milk fat globule membrane) providing phospholipids and proteins, HMOs (human milk oligosaccharides) providing prebiotic and immunomodulatory functions, and fat supplements (DHA, ARA) providing essential fatty acids. Each segment has a defined role and concentration range, making the complex formulation manageable through modular design while maintaining synergistic interactions between segments.
Solution Approach 2:
The patent designs ingredients with multiple functions to reduce overall formulation complexity. For example, MFGM serves multiple purposes: providing phospholipids for cell membrane structure, proteins for enzymatic functions, and serving as a carrier for fat-soluble vitamins. HMOs provide both prebiotic effects and immunomodulatory functions. This multi-functionality allows fewer ingredients to achieve multiple health benefits, simplifying the formulation while enhancing health outcomes.
Data Source
AI summary
A nutritional composition that includes a milk fat globule membrane component, at least one human milk oligosaccharide, and at least one additional component chosen from the group consisting of DHA, ARA, Vitamin E, Vitamin C, and sphingomyelin. The nutritional composition is in the form of a ready-to-drink composition, a food supplement, an extruded food bar, or a solid oral dosage form. The nutritional composition is typically administered or provided to adults, children, or infants through consumption.